Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide <i>in vivo</i>
Jianbing Wu(China Pharmaceutical University), Zhangjian Huang(Xinjiang Medical University), Yihua Zhang(China Pharmaceutical University), Jianhua Wang(Dalian Ocean University), Hu‐Lin Jiang(China Pharmaceutical University), Yue Xu(Tianjin University of Traditional Chinese Medicine), Yu‐Yang Bi(China Pharmaceutical University), Yong Ling(Nantong University), Hao Wen(Xinjiang Medical University), Tao Sun(Xinjiang Medical University), Chenxi Yang(China Pharmaceutical University), Tian Lv(China Pharmaceutical University), Fei Li(Xinjiang Medical University), Jun Zhao(Nanjing Medical University), Rigang Cong(Enterprise Community Partners)
Cited by 12
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
|Hepatology International|2020|130
A Novel Liver X Receptor Agonist Establishes Species Differences in the Regulation of Cholesterol 7α-Hydroxylase (CYP7a)
|Endocrinology|2002|76